Kestra Private Wealth Services’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
RP
DM
BG
Kestra Private Wealth Services's AMED Position: Q4 2022 in Review
Kestra Private Wealth Services sold out of Amedisys (AMED) in Q4 2022, closing a stake of 2,555 shares — an estimated $247K sold.
Kestra Private Wealth Services first reported a position in AMED in Q3 2021 and held it in 5 quarters. The position peaked at $970K in Q3 2021. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.
- Kestra Private Wealth Services reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
- Kestra Private Wealth Services sold 2,555 Amedisys shares in Q4 2022, an estimated $247K.
- Kestra Private Wealth Services first reported a position in Amedisys in Q3 2021 and held it in 5 quarters.
- Kestra Private Wealth Services's Amedisys position peaked at $970K in Q3 2021.
- 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.
Based on Kestra Private Wealth Services's 13F filing for Q4 2022, filed 1 Feb 2023.